As of August 2026, 53 paid clinical trials are recruiting in Normal, Illinois. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Normal offers studies at sites including Carle Cancer Institute Normal for conditions such as Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Recurrent Endometrial Carcinoma, Anatomic Stage I Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Normal, IL at 8 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Carle Cancer Institute Normal | Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Recurrent Endometrial Carcinoma | 44 |
| Carle BroMenn Medical Center | Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Recurrent Endometrial Carcinoma | 39 |
| Sneeze Wheeze & Itch Associates | Atopic Dermatitis, Chronic Obstructive Pulmonary Disease | 2 |
| GSK Investigational Site | Asthma | 1 |
| Midwest Allergy Sinus Asthma | Clonal Mast Cell Disease, KIT D816V Mutation, Suspected KITD816V Mutated Clonal Mast Cell Disease | 1 |
| Midwest Allergy Sinus Asthma SC | Chronic Spontaneous Urticaria (CSU) | 1 |
| Nektar Investigative Site | Moderate-to-Severe Atopic Dermatitis | 1 |
| Sneeze, Wheeze, & Itch Associates, LLC | Atopic Dermatitis | 1 |
Recruiting trials in Normal grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 53 recruiting clinical trials in Normal, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Normal compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Normal include Malignant Solid Neoplasm (6), Anatomic Stage II Breast Cancer AJCC v8 (4), Recurrent Endometrial Carcinoma (3), Anatomic Stage I Breast Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Normal on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Normal include Carle Cancer Institute Normal, Carle BroMenn Medical Center, Sneeze Wheeze & Itch Associates, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Normal are Cancer & tumors (37), Mental health & behavior (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.